Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Charles River Laboratories Intl (CRL)

Charles River Laboratories Intl (CRL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 6,792,040
  • Shares Outstanding, K 48,839
  • Annual Sales, $ 2,266 M
  • Annual Income, $ 226,370 K
  • 60-Month Beta 1.08
  • Price/Sales 2.97
  • Price/Cash Flow 14.51
  • Price/Book 4.37

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate 1.83
  • Number of Estimates 8
  • High Estimate 1.85
  • Low Estimate 1.80
  • Prior Year 1.49
  • Growth Rate Est. (year over year) +22.82%

Price Performance

See More
Period Period Low Period High Performance
1-Month
125.39 +9.21%
on 10/24/19
139.18 -1.61%
on 11/15/19
+2.66 (+1.98%)
since 10/18/19
3-Month
123.61 +10.79%
on 10/02/19
140.10 -2.26%
on 09/20/19
+7.10 (+5.47%)
since 08/16/19
52-Week
103.00 +32.95%
on 01/03/19
149.07 -8.13%
on 04/03/19
+6.06 (+4.63%)
since 11/16/18

Most Recent Stories

More News
Charles River Laboratories to Present at Upcoming Investor Conferences

Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at three upcoming investor conferences, including:

CRL : 136.94 (-1.53%)
After Yesterday's Decline of 3.73%, Charles River La Offers Investors Better Value

Charles River La (NYSE:CRL) traded in a range yesterday that spanned from a low of $126.30 to a high of $133.89. Yesterday, the shares fell 3.7%, which took the trading range below the 3-day low of $130.54...

CRL : 136.94 (-1.53%)
Charles River: 3Q Earnings Snapshot

WILMINGTON, Mass. (AP) _ Charles River Laboratories International Inc. (CRL) on Wednesday reported third-quarter net income of $72.8 million.

CRL : 136.94 (-1.53%)
Charles River Laboratories Announces Third-Quarter 2019 Results

--- Third-Quarter GAAP Earnings per Share of $1.46 and Non-GAAP Earnings per Share of $1.69 -

CRL : 136.94 (-1.53%)
Healthcare Stock Earnings Slated on Nov 6: HUM, ELAN & More

Rise in senior population, shift of care to lower-cost settings and decline in unemployment are likely to have driven healthcare sector earnings.

HUM : 334.54 (-0.30%)
LHCG : 130.12 (+0.32%)
CRL : 136.94 (-1.53%)
ELAN : 25.54 (-2.18%)
Charles River Laboratories (CRL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Charles River (CRL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CRL : 136.94 (-1.53%)
Charles River Laboratories Announces Closing of Senior Notes Offering

Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it has closed its previously announced offering of $500 million in aggregate principal amount of its 4.25% senior notes due...

CRL : 136.94 (-1.53%)
Charles River Laboratories Schedules Third-Quarter 2019 Earnings Release and Conference Call

Charles River Laboratories International, Inc. (NYSE: CRL) will release third-quarter 2019 financial results on Wednesday, November 6th, before the market opens. A conference call has been scheduled to...

CRL : 136.94 (-1.53%)
Charles River Laboratories Announces Offering of $500 Million of Senior Notes

Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it intends to offer $500 million in aggregate principal amount of senior notes due 2028 (the "notes") in an unregistered...

CRL : 136.94 (-1.53%)
Charles River Laboratories Demonstrates Industry-Leading Research at Neuroscience 2019

Charles River Laboratories International, Inc. (NYSE: CRL) today announced that its team of neuroscience drug discovery experts will present 37 scientific posters, both independently and collaboratively...

CRL : 136.94 (-1.53%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

See More Share

Trade CRL with:

Business Summary

Charles River Laboratories International, Inc. provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Their dedicated employees are focused...

See More

Key Turning Points

2nd Resistance Point 139.92
1st Resistance Point 138.43
Last Price 136.94
1st Support Level 135.93
2nd Support Level 134.92

See More

52-Week High 149.07
Last Price 136.94
Fibonacci 61.8% 131.47
Fibonacci 50% 126.03
Fibonacci 38.2% 120.60
52-Week Low 103.00

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar